Project Grant R01GM158745

Award Date 6/1/25
Completion Date 3/31/29
Dollars Obligated $452K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will provide $1,557,497 to Vanderbilt University to conduct research on the structural requirements and conformational dynamics of sterol 14α-demethylases (CYP51) enzymes. The research aims to gain new mechanistic insights into CYP51 enzyme function and inhibition, as well as uncover the structural basis for its possible role in P450...
This $778,444 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to investigate the structure and function of phospholipids and inositol phosphates in the cell nucleus. The 5-year project at Vanderbilt University Medical Center, beginning May 2025, aims to reveal the structural biology and functional genomics of these nuclear signaling molecules. Key objectives include...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $396,250.00 to Vanderbilt University to conduct research on the regulation and function of biomolecular condensates. The research aims to define the core biochemical principles underlying the spatial and temporal regulation of P granule polarization during C. elegans embryogenesis, using P granules as a model condensate. Key...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $422,569 in funding to Vanderbilt University to develop new reactions and reagents for generating enantioenriched organic compounds. The goal is to enable the concise synthesis of valuable precursors to medicinal agents and biologically active natural products, with a focus on secondary amines, tertiary amines, and vicinal diamines. The...
The National Institute of General Medical Sciences (NIGMS) awarded a $395,943 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Vanderbilt University. The goal of this 5-year research program is to develop advanced spectroscopic methods using two-dimensional infrared (2D IR) spectroscopy to study protein structure and dynamics within complex biological environments. The key objectives are to: 1) Leverage unnatural amino acid labels and 2D IR to map...
The National Institute of General Medical Sciences (NIGMS) awarded Vanderbilt University a 5-year, $395,881 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to develop new protocols for altering the molecular topology of biologically active natural products and therapeutic compounds. The key products to be delivered through this grant include: 1) Photochemical deconstructive epimerization protocols involving C-C bond cleavage, radical intermediate formation, and C-C bond...
This $150,000 Project Grant awarded by the National Science Foundation's Mathematical and Physical Sciences (CFDA 47.049) program funds research at Vanderbilt University to elucidate the molecular mechanisms of DNA repair by a newly discovered bacterial enzyme. The project aims to understand how this enzyme protects microbes against toxic natural products, with the long-term goals of elucidating bacterial interstrand DNA crosslink repair pathways and discovering new genotoxic agents with...
This federal Project Grant award for $1,188,381.00, made by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), aims to harness evolutionary adaptation to identify novel molecular mechanisms modulating the environmental stress response. The research will focus on studying protein-level mechanisms regulating cytoprotective programs in animal specialists, such as fishes, whales, and birds, that have evolved to...
This federal Project Grant award in the amount of $2,399,874.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research at Vanderbilt University Medical Center, the grant recipient, aims to decode the inflammatory response and unravel the molecular basis of post-injury syndrome...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $931,844 to Vanderbilt University to conduct research on the functional roles of human cytochrome P450 enzymes. The key research objectives include: determining if the compound I intermediate (FeO3+) is the only oxidant involved in P450 reactions, identifying the physiological roles of the remaining "orphan" human...

This federal Project Grant award, worth $452,192, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant supports the "Development of Pan- and Phospho-Specific Nanobodies for Investigating MAPK and PP2A Signaling" project at Vanderbilt University. The research aims to enhance understanding of the reversible protein phosphorylation processes that regulate cellular homeostasis, with a focus on protein kinases and phosphatases. The award period runs from June 1, 2025 to March 31, 2029. Vanderbilt University, a leading private research institution, will conduct this comprehensive basic and translational biomedical research effort through its Sponsored Programs Administration division.

Generated 6/17/25, 5:00 AM